Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-04-04
2006-04-04
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C548S517000, C548S527000, C548S533000, C548S537000
Reexamination Certificate
active
07022677
ABSTRACT:
Disclosed are the novel compounds as growth hormone secretagogues represented by structural Formula (I), wherein R1is, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, or substituted or unsubstituted amino, X is —CO— or —SO2—, Y is Formula (II), wherein n is an integer from 0–4, R4is hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, R5and R6are independently selected from hydrogen, substituted or unsubstituted alkyl, or R5and R6or R4and R5are taken together to form substituted or unsubstituted alkylene, R2is hydrogen, or substituted or unsubstituted alkyl, R3is substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, D is substituted or unsubstituted amino, substituted or unsubstituted alkoxy, or substituted or unsubstituted alkylthio, * represents an asymmetric center, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
REFERENCES:
patent: 4093713 (1978-06-01), Sestanj et al.
patent: 4250192 (1981-02-01), Sallmann et al.
patent: 4560506 (1985-12-01), Weller et al.
patent: 4626545 (1986-12-01), Taub
patent: 4766110 (1988-08-01), Ryan et al.
patent: 4927809 (1990-05-01), Stuber
patent: 5439930 (1995-08-01), Seredenin et al.
patent: 5525623 (1996-06-01), Spear et al.
patent: 5869671 (1999-02-01), Wang et al.
patent: 5948887 (1999-09-01), Evans et al.
patent: 5952465 (1999-09-01), Evans et al.
patent: 5965698 (1999-10-01), Evans et al.
patent: 6084066 (2000-07-01), Evans et al.
patent: 6100047 (2000-08-01), Wilkison et al.
patent: 6100069 (2000-08-01), Biswas et al.
patent: 6133456 (2000-10-01), Holt et al.
patent: 6147189 (2000-11-01), Evans et al.
patent: 6150527 (2000-11-01), Holt et al.
patent: 2002/0137686 (2002-09-01), Ternansky et al.
patent: 2002/0161240 (2002-10-01), Holt et al.
patent: WO93/04081 (1993-03-01), None
A Pollak, et al. J. Am. Chem. Soc. (1999) 121, 11593-11594.
Sarantakis et al, “Solid Phase Synthesis of Sec-Amides and Removal from the Polymeric Support Under Mild Conditions”, Tetrahedron Letters, vol. 38, No. 42, pp. 7325-7328, 1997; XP004111205.
Stuerzeberger et al, “Synthetische Inhibitoren der Serinproteasen”, Pharmazie, Veb Verlag Volk Und Gesundheit. Berlin, DD, vol. 42, No. 2, 1987, pp. 114-116, XP002169714.
Santamaria et al, “Synthesis of Tryptophan-dehydrobutyrine Diketopiperazines and Analogues”, Tetrahedron, vol. 55, No. 4, Jan. 22, 1999, pp. 1173-1186; XP004151339.
Walpole et al, “2-Nitrophenylcarbamoyl-(S)-Prolyl-(S)-3-(2-Nahthyl)Alanyl-N-Benzyl-N-Methylamide (SDZ NKT 343), A Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models”, Journal of Medicinal Chemistry, American Chemical Society, vol. 41, No. 17, Aug. 13, 1998, pp. 3159-3173, XP000972902.
Yang et al, “Tripeptide Growth Hormone Secretagogues”, Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 7, Apr. 7, 1998, pp. 759-764, XP004136961.
Nargund et al, “Peptidomimetic growth hormone secretagogues: synthesis and biological activities of analogs varied at the indole nucleus of the prototypical spiropiperidine L-162,752”, Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 14, Jul. 23, 1996, pp. 1731-1736, XP004134930.
Huang Ping
Inoguchi Kiyoshi
Ishige Hirohide
Ishiyama Nobuo
Kiyofuji Takeshi
Campell Bruce R.
Kaken Pharmaceutical Co. Ltd.
Kosar Andrew D.
Molecular Research Institute
LandOfFree
Amide derivatives as growth hormone secretagogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives as growth hormone secretagogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives as growth hormone secretagogues will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3573698